Press Release – New York, NY – April 29, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage immunology company focused on …
Sichenzia Ross Ference Carmel LLP Represents INmune Bio Inc. in $4.8 Million Registered Direct Offering
Press Release – New York, NY – April 24, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage immunology company focused on …
Sichenzia Ross Ference LLP and Carmel, Milazzo & Feil, LLP Complete Combination to Form Sichenzia Ross Ference Carmel LLP (SRFC)
NEW YORK, Oct. 02, 2023 -- Sichenzia Ross Ference LLP (“SRF”) and Carmel, Milazzo & Feil, LLP (“CMF”) announced today the completion of their combination to form Sichenzia Ross Ference Carmel LLP …
Sichenzia Ross Ference LLP Represents mCloud Technologies Corp., a Canadian Public Company, in $9.5 Million Underwritten Public Offering Made under the MJDS in the US and Uplisting to Nasdaq
Press Release – New York, NY – November 30, 2021 – Sichenzia Ross Ference LLP announced today that it represented mCloud Technologies Corp. (Nasdaq: MCLD) (TSXV: MCLD), a leading provider of …